An exterior of China Evergrande Centre in Hong Kong on March 26, 2018. Photo: REUTERS

Evergrande Health pays US$930 million to buy control of carmaker in its foray into mass production of electric vehicles in China

  • Evergrande’s unit will pay US$930 million for 51 per cent of National Electric Vehicle Sweden (NEVS), which is a consortium owned by Tianjin’s government and a state think tank
  • NEVS is one of 10 Chinese carmakers whose models meet the standards for mass production in China
Topic |   Electric cars

TOP PICKS

An exterior of China Evergrande Centre in Hong Kong on March 26, 2018. Photo: REUTERS
READ FULL ARTICLE